Document is current
Any future updates will be listed below
-
Authors
,
Maasakkers, Carlijn M. http://orcid.org/0000-0001-9414-1397
Claassen, Jurgen A. H. R.
Gardiner, Paul A.
Olde Rikkert, Marcel G. M.
Lipnicki, Darren M.
Scarmeas, Nikolaos
Dardiotis, Efthimios
Yannakoulia, Mary
Anstey, Kaarin J.
Cherbuin, Nicolas
Haan, Mary N.
Kumagai, Shuzo
Narazaki, Kenji
Chen, Tao
Ng, Tze Pin
Gao, Qi
Nyunt, Ma S. Z.
Crawford, John D.
Kochan, Nicole A.
Makkar, Steve R.
Sachdev, Perminder S.
Thijssen, Dick H. J.
Melis, René J. F.
-
Funding
Funding for this research was provided by:
national health and medical research council of australia (110331)
National Institute on Aging (1RF1AG057531-01)
australian national health and medical research council (APP1100579)
Alzheimer's Association (IIRG-09-133014)
ESPA-EU (189 10276/8/9/2011)
European Social Fund and Greek National resources (ΔΥ2β/οικ.51657/14.4.2009)
National Health and Medical Research Council (1002160, APP1102694)
National Institutes of Health (AG12975)
National Institute of Environmental Health Sciences (ES023451)
Japan Society for the Promotion of Science (JP17K09146)
Agency for Science Technology and Research (03/1/21/17/214, 08/1/21/19/567)
National Medical Research Council (NMRC/1108/2007)
- License Information
-
More Information
Article History
First Online: 16 September 2019
Compliance with Ethical Standards
: This work was supported by the National Health and Medical Research Council of Australia and Australian Research Council (Dementia Research Development Fellowship #110331 to PG). Funding for COSMIC comes from a National Health and Medical Research Council of Australia Program Grant (ID 1093083), the National Institute On Aging of the National Institutes of Health under Award Number RF1AG057531, and philanthropic contributions to The Dementia Momentum Fund (UNSW Project ID PS38235).The HELIAD study was supported by an Alzheimer’s Association , Grant/Award Number: IIRG‐09‐133014; an ESPA‐EU program Excellence , Grant/Award Number: 189 10276/8/9/2011; an European Social Fund and Greek National resources; Ministry for Health and Social Solidarity , Grant/Award Number:ΔΥ2β/οικ.51657/14.4.2009 to NS. The PATH study was funded by supported by NHMRC Grant #1002160, and KA is funded by NHMRC Fellowship APP1102694. The SALSA study was supported by funds NIH , AG12975 and NIEHS , ES023451 to MH. The SGS study was supported by JSPS , KAKENHI Grant Number JP17K09146 to KN. The SLAS2 study was supported by research grants from the Agency for Science Technology and Research (A*STAR) Biomedical Research Council (BMRC) [Grants 03/1/21/17/214 and 08/1/21/19/567] and the National Medical Research Council [Grant: NMRC/1108/2007] to TN, QG & MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funders.
: Nikolaos Scarmeas reports personal fees from Merck Consumer Health, Personal fees from NIH, grants from EISAI, outside the submitted work. Perminder S. Sachdev reports and is in the Australian Advisory Board of Biogen. Carlijn M. Maasakkers, Jurgen A. H. R. Claassen, Paul A. Gardiner, Marcel G. M. Olde Rikkert, Darren M. Lipnicki, Efthimios Dardiotis, Mary Yannakoulia, Kaarin J. Anstey, Nicolas Cherbuin, Mary N. Haan, Shuzo Kumagai, Kenji Narazaki, Tao Chen, Tze Pin Ng, Qi Gao, Ma S. Z. Nyunt, John D. Crawford, Nicole A. Kochan, Steve R. Makkar, Dick H. J. Thijssen, and René J. F. Melis declare that they have no conflicts of interest.
